Morepen launches Empamore for diabetes care with affordable treatment
Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
The programme will take place on the 2nd Sunday of every month
Announces Rs. 317 crore investment in new recycling plant
Encourages working women to practice self-care
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
Subscribe To Our Newsletter & Stay Updated